Small Molecules for Precision Medicine

Learn More about Arqule

We are pursuing multiple programs in biomarker-defined oncology and rare disease indications

Targeted Approach to Cancer

Clinical Trials

Learn More

Research & Development

Product Pipeline

Explore

Targeted Approach To

Rare Diseases

Read More

News & Events

September 29, 2017
Proteus Syndrome Phase 1 Data Presentation
Watch Video »
July 13, 2018
ArQule Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
Read More »
July 18, 2018
ArQule to Report Second Quarter 2018 Financial Results on August 1, 2018
Read More »

More News & Events »

arqule

© Copyright ArQule. All rights reserved. Terms of Use.